Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XLT: Latanoprost vs Travoprost vs Bimatoprost in Glaucoma/OHT
NCT00847483Phase 4Completed
- Sponsor
- Viatris
- Start
- Jan 2002
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of latanoprost ophthalmic solution 0.005% (TearClear TC-002) in Glaucoma, ocular hypertension, sponsored by Viatris. Started Jan 2002; status: completed.
02
Drugs
latanoprost ophthalmic solution 0.005% (TearClear TC-002)
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00847483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847483.